GROUP ONE TRADING, L.P. - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is and the CUSIP is 74587V957. A total of 3 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$5,260
-72.9%
2,000
-63.6%
0.00%
Q2 2023$19,415
+96.3%
5,500
+71.9%
0.00%
Q1 2023$9,888
+233.9%
3,200
+357.1%
0.00%
Q4 2022$2,961
-50.6%
700
-68.2%
0.00%
Q2 2022$6,000
-96.3%
2,200
-96.1%
0.00%
Q1 2022$162,000
-9.5%
56,300
-4.4%
0.00%
Q4 2021$179,000
+17800.0%
58,900
+58800.0%
0.00%
Q3 2021$1,000
-98.7%
100
-98.8%
0.00%
Q2 2021$79,000
+92.7%
8,600
+104.8%
0.00%
Q1 2021$41,000
-69.6%
4,200
-68.2%
0.00%
Q4 2020$135,000
+6.3%
13,200
+4.8%
0.00%
Q3 2020$127,000
-8.6%
12,600
-5.3%
0.00%
-100.0%
Q2 2020$139,000
-7.9%
13,300
-25.7%
0.00%0.0%
Q1 2020$151,000
-37.6%
17,900
-35.1%
0.00%
-50.0%
Q4 2019$242,000
-20.9%
27,600
+249.4%
0.00%
-33.3%
Q1 2019$306,000
-27.7%
7,900
-62.0%
0.00%
-25.0%
Q4 2018$423,000
-75.3%
20,800
-44.2%
0.00%
-71.4%
Q3 2018$1,710,000
-40.6%
37,300
-23.4%
0.01%
-44.0%
Q2 2018$2,881,000
-15.5%
48,700
-2.8%
0.02%
-26.5%
Q1 2018$3,409,000
-41.4%
50,100
-14.9%
0.03%
-17.1%
Q4 2017$5,822,000
+25.0%
58,900
+51.4%
0.04%
-2.4%
Q3 2017$4,658,000
-69.6%
38,900
-77.8%
0.04%
-73.6%
Q2 2017$15,312,000
+442.4%
175,200
+130.8%
0.16%
+381.8%
Q1 2017$2,823,000
+74.8%
75,900
+44.3%
0.03%
+106.2%
Q4 2016$1,615,000
-80.8%
52,600
-58.1%
0.02%
-82.4%
Q3 2016$8,421,000
+1291.9%
125,600
+518.7%
0.09%
+1200.0%
Q2 2016$605,000
+124.1%
20,300
+120.7%
0.01%
+75.0%
Q1 2016$270,000
-86.7%
9,200
-64.3%
0.00%
-83.3%
Q4 2015$2,023,000
-39.3%
25,800
-41.6%
0.02%
-47.8%
Q3 2015$3,331,000
-38.5%
44,200
-4.7%
0.05%
-39.5%
Q2 2015$5,417,000
+3086.5%
46,400
+5055.6%
0.08%
+2433.3%
Q4 2014$170,000
-89.8%
900
-87.1%
0.00%
-88.5%
Q3 2014$1,670,000
-52.6%
7,000
-86.9%
0.03%
-51.9%
Q2 2014$3,524,000
+284.7%
53,400
+506.8%
0.05%
+260.0%
Q1 2014$916,000
+110.6%
8,800
+109.5%
0.02%
+114.3%
Q4 2013$435,0004,2000.01%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 416$7,874,0000.25%
SIMPLEX TRADING, LLC 89$392,0000.05%
GROUP ONE TRADING, L.P. 900$170,0000.00%
Citadel Advisors 13,300$2,517,0000.00%
View complete list of PUMA BIOTECHNOLOGY INC shareholders